Correlation Engine 2.0
Clear Search sequence regions

  • azithromycin (1)
  • babesiosis (5)
  • clindamycin (1)
  • human (4)
  • tick (1)
  • Sizes of these terms reflect their relevance to your search.

    Human babesiosis is reported throughout the world and is endemic in the northeastern and northern Midwestern United States and northeastern China. Transmission is primarily through hard bodied ticks. Most cases of severe disease occur in immunocompromised individuals and may result in prolonged relapsing disease or death. We provide a summary of evidence supporting current treatment recommendations for immunocompetent and immunocompromised individuals experiencing babesiosis. Most cases of human babesiosis are successfully treated with atovaquone and azithromycin or clindamycin and quinine. Severe disease may require prolonged treatment.


    Robert P Smith, Klaus-Peter Hunfeld, Peter J Krause. Management strategies for human babesiosis. Expert review of anti-infective therapy. 2020 Jul;18(7):625-636

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 32268823

    View Full Text